Should you buy Palatin Technologies stock now?
No, the technical signal for Palatin Technologies is currently Strong Sell. Palatin Technologies trades at $6.23 as of Nov 14, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -0.345 with rising momentum (signal: -0.643); RSI is at 45.5 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average). The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Palatin Technologies stock?
There is currently no active analyst price target for Palatin Technologies.
Is Palatin Technologies a dividend stock?
No, Palatin Technologies does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Palatin Technologies stock?
Palatin Technologies is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 125.8%, which classifies the stock as Extremely speculative.
Is Palatin Technologies overvalued?
Palatin Technologies has the following valuation ratios: a P/S ratio of 0.9, a P/B ratio of 1.8.
Is Palatin Technologies overbought?
No, Palatin Technologies is not overbought. RSI is at 45.5 (neutral zone). The technical indicators show: RSI is at 45.5 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 9.0% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Palatin Technologies earnings report?
The date of the next earnings report for Palatin Technologies has not been published yet. Check the company's investor calendar for updates.
Is Palatin Technologies shorted?
Yes, Palatin Technologies is shorted with 22.2% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Palatin Technologies stock?
No, insiders are not buying Palatin Technologies shares – they are net sellers. Across the last 8 reported transactions, the split is 2 purchases and 6 sales, with a net 32,071 USD sold. Active sellers include WILLS STEPHEN T, DEVEER ROBERT K JR, DUNTON ALAN W. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Palatin Technologies a good stock?
Based on our total score, Palatin Technologies is rated as a disastrous stock with a total score of 18 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 42/100, Quality: 8/100, Momentum: 4/100. Whether now is the time to buy is a separate question: the technical signal is Strong Sell. Whether Palatin Technologies is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Palatin Technologies stock?
The outlook for Palatin Technologies based on current data: the stock is in a downtrend (below SMA50 and SMA200). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Palatin Technologies stock rising?
Palatin Technologies is rising right now. The technical indicators show: the price is 9.0% above the 20-day average; short interest is 22.2% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Palatin Technologies go?
There is currently no active analyst price target for Palatin Technologies. The stock has traded between $4.51 and $31.00 over the last 52 weeks. The price is 79.9% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Palatin Technologies fall?
The stock has traded as low as $4.51 over the last 52 weeks — that is 27.6% below the current price of $6.23. The biggest decline (drawdown) in the same period was 85.5% from high to low. Within a year, the price typically swings about ±125.8% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Palatin Technologies do?
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-a... The company belongs to the Healthcare sector, more specifically the Biotechnology industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Palatin Technologies as an investment.
Did Palatin Technologies raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Palatin Technologies. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Palatin Technologies making money or losing money?
No, Palatin Technologies is currently not making money — the company is losing money with a negative profit margin of -63.5%, a substantial loss. That means the business loses money on every dollar of revenue. The operating margin (profit before interest and taxes) is also negative at -65.7% — so it is not just financing costs weighing on the result. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Palatin Technologies go bankrupt?
The bankruptcy risk of Palatin Technologies is rated as elevated. Altman Z2 (a model for assessing financial distress) is -176.70 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 4 — which is average. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Palatin Technologies have a lot of debt?
Yes, Palatin Technologies has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.